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Growth Control and Differentiation in
Mammary Epithelial Cells
by Flavia Borellini* and Takami Oka*
Growth and differentiation ofthe mammary gland are controlled by various hormones and other environ-
mental factors The role ofhormones and growth factors in mammary development is discussed with regard
to animal species, physiological stages, and the various experimental systems in vitro. In the female embryo,
mammary morphogenesis is induced by the mesenchyme and is hormone independent, whereas androgens
cause the partial necrosis ofmammary epithelium in the male. Ductal growth during adolescence requires
estrogen andprolactin orgrowth hormone. Duringpregnancy, progesterone participates in the development
ofthe lobuloaveolar structure ofthe gland. Afterparturition, changes in the hormonal environment lead to
production and secretion ofmilk. Proliferation and differentiation ofmammary epithelium can be induced
in culture systems. Insulin andepidermal growth factor(EGF) stimulate mammary cell proliferation in vitro.
EGF is required forthe optimal growth ofthe mammary gland duringpregnancy. EGF also appears to play
an important role in mammary tumorigenesis in certain mouse strains. Production ofmilk proteins can be
induced in vitrobythe synergistic interactions ofprolactin, insulin, and glucocorticoids and is inhibited by
EGF andprogesterone. Complete orpartial sequencingofseveral milkprotein genes andcomparative anal-
ysis have led to identification ofa sequence ofhigh homology and conservation in the 5'flankingregion that
is likely to be involved in the regulation ofmilk protein gene expression.
Introduction
In recent years, biomedical studies have focused on
understanding the mechanisms regulating cell growth
and differentiation. Forthis purpose, the mammarygland
serves as a very suitable experimental systembecause of
its characteristic pattern ofmorphological andfunctional
development.
Most tissues and organs undergo massive growth in the
early stages of development, i.e., during embryogenesis
and inthe earlyperiodofpostnatallife. Bycontrast, mam-
mary tissue expresses its maximumgrowthpotential af-
terthe animal has reachedmaturity, that is, followingthe
onset of pregnancy and during lactation. Moreover, this
growth potential ismaintained throughout the reproduc-
tive life of the animal, and, to some extent, even there-
after. The cycle ofproliferation-differentiation-regression
is repeated at each gestation, and can be reproduced in
culture systems in vitro. The characteristic physiological
pattern of mammary gland development is regulated by
several factors; endocrine control is the most obvious and
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perhaps the best understood, but several studies have
provided evidence thatparacrine, autocrine, and intracel-
lularfactors, as well as the extracellularmatrix, can also
affect the growth and differentiation processes.
The availability ofmolecular biological techniques has
given investigators anewpossible approach to theunder-
standing of the complex mechanisms of regulation of
mammary gland function. Studies on the structure and
expression ofmilkprotein genes have provided valuable
information to the overallpicture. A deeperunderstand-
ingofhowgrowth and differentiation ofthe mammary tis-
sue are regulated could complement the knowledge of
developmental processes and also provide invaluable
informationfor clinical treatment andprevention ofmam-
mary cancer.
Several excellent reviews(1-7')giving anextensive over-
view of the growth and development of the mammary
gland have been published. In this review, we have fo-
cused onthe recentprogress made inthisfield, with spe-
cial attention to the interactions between the different
regulatory factors and their mechanisms of action.
Outline of Mammary Gland
Development
The mammary tissuefrom different specieshas avery
similar structural organization, although hormonal re-BORELLINI AND OKA
quirements forthe growth and expression ofthe specific
function ofthe gland vary amongvarious strains or spe-
cies. The following is a brief account of developmental
changes ofthe mammary gland.
Embryogenesis
The embryonal development of mammary tissue ap-
pears to be comparable in all species (8,9). In the mouse,
the development inthemale and inthefemalefollows the
same pattern up to about the day 13 ofembryonal life; at
day 11, an areaofraised ectoderm isformed onboth sides
ofthe trunk, and the neighbouring ectodermal cells be-
ginto congregate around this areato form themammary
band (Fig. 1A). The migration of the epidermal cells to
preferential centers ofcongregation gives rise to the in-
dividual buds (8,9) (Fig. 1B).
The critical difference between male and female em-
bryos in the development ofthe mammary tissue occurs
between days 13 and 15. In the female, at day 15 of em-
bryonic life, the mammary bud cells undergo a phase of
rapid proliferation, giving rise to the mammary cord, a
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FIGURE 1. Formation of the mammary cord in the mouse embryo be-
tween days 11 and 15 ofgestation. (A) Mammary band, day 11; (B)
mammary bud, day 12-13; (C) mammary cord, day 15.
band of epithelial cells elongated into the mesenchyme
but still connectedto the epidermis byacollarofectoder-
mal cells(Fig. 1C). Atthe endofgestation, themammary
epithelium in thefemale embryo consists ofacord ofcells,
embedded in the mesenchyme and partially canalized.
The cord opens at the apex, where the future nipple will
be formed, andbegins to show some branchingatthe dis-
tal end.
In the male embryo, a series ofevents takes place be-
tween days 13 and 15 as aresult ofthe androgen produc-
tion by the fetal testes (10). The mesenchyme condenses
allaroundthemammarybud, whichbecomesisolatedinto
the subepidermal tissue. The bud eventually becomes a
rudimentary epithelial cord, but no further development
occurs. In the mouse, the mesenchymal condensation
leads eventually to the partial ortotal destruction ofthe
mammarybud; inratandrabbitembryosthenecrosis of
the mammary rudiment does not occur.
From Birth to Maturity
The prepubertal development of the mammary gland
occurs in two distinct phases. Up to day 22 to 23 oflife,
the development oftheglandis mainly due to an increase
in connective tissue and deposition offat. The increase in
size parallels the increase in body weight, and is there-
fore referred to as isometric growth; it does not seem to
depend on hormones. During the 2 weeks preceding
puberty, the mammaryglandgrows atarate aboutthree
times greater than that of the body weight. This phase
is referred to as allometric growth, and canbe prevented
by ovariectomy (2).
Sexual maturation in the mouse occurs during week 4
to 6 of postnatal life. During this phase the mammary
epithelium in the female grows extensively and extends
throughoutthefatpad. Veryfewalveoliareformedatthis
time; thegrowthpattern is three-dimensional and canbe
simulated in cultures ofmammary epithelium into a col-
lagen matrix (11). Elongation ofthe ducts occurs as a re-
sult ofrapid growth in end buds, which, by turning and
branching, give rise to the characteristictree-shaped pat-
tern ofthe mammary ductal system. The end bud tip is
covered with a monolayer of epithelium, the cap cells,
which are characterized by a relative lack ofspecialized
features. These cells have been defined as a stem cell
population; as the duct elongates, the cap cellsgradually
differentiate to provide new myoepithelial cells for duc-
tal morphogenesis and elongation (12). In human breast
tissue, myoepithelial cells also originatefromaprecursor
population within the epithelium after a number of cell
divisions (13). Duringthe different stages ofmouse mam-
mary gland development, myoepithelial cells undergo
several changes in size and shape (14). The stroma sur-
rounding the elongating end bud shows a significant in-
crease in DNA synthesis (15).
As the mouse reaches sexual maturity at 6 to 8 weeks
ofage, the development ofthe ductal structure stops, in
spite ofthe presence ofthe major hormonal stimuli (i.e.,
estrogen produced by the ovaries), for ductal growth.
Some residualmitotic activityisobserved atthe endbuds
86MAMMARY EPITHELIAL CELLS
in the mature mouse gland during estrus (16). At this
stage, the mammary gland shows ductal ramifications
throughout the mammary fat pad; however, a clear zone
of fat pad remains between the ducts. This interductal
space will eventually be occupiedbylobules duringpreg-
nancy.
Pregnancy
Following the onset of pregnancy, cell replication re-
sumes. During the first period, ductal growth occurs ex-
tensively, and the ducts undergo furtherbranching. The
interstitial adipose tissue disappears progressively, and
proliferating epithelial cells fill the interductal spaces.
Duringthe middle andlate period ofpregnancy, epithelial
cells continue tomultiply tofonnthe lobuloalveolar struc-
ture. Aspregnancy approaches term, the alveoli startto
show secretory activity, and the epithelial cells become
distended, with agranularcytoplasm (17,18)(Fig. 2). In-
creased vascularization ofthe gland and loss offat in fat
padcells seemtobeinducedbytheproliferatingepithelial
cells. In ratmammarygland, theproliferative activity is
also higher during estrus and pregnancy than during
nonestrus and lactation (19).
Lactation
Functional differentiation ofmammary epithelial cells
culminates in lactogenesis. Lactating tissue shows the
typicalfeatures ofa secretoryepithelium. Cells are highly
polarized, both functionally and morphologically, are con-
nected by tightjunctions, and the surfaces that face the
cavity ofthe alveoli are covered with microvilli. A large
part ofthe cytoplasm is occupied by rough endoplasmic
reticulum; the well-developed Golgi apparatus is located
in the apical region. Small droplets offat are present all
over the cytoplasm (Fig. 2). The epithelium and the sur-
rounding myoepithelial cells are enclosed by the basal
lamina, which provides a boundary between the
epithelium and the stromal tissue.
In the mouse, milk yield is maximum at day 15 oflac-
tation. After day 15 a sharp drop occurs, followedby a de-
crease in the synthetic activity of the gland and in cell
population. When lactation is extended by substituting
youngerpups to the original litter at day 15, cell number
and differentiation aremaintained eventhough at alower
degree (20).
Involution
Natural weaning is usually a gradual process, and the
progressive decrease in the suckling stimulation results
in involution of the gland. The major changes of involu-
tiontakeplace inthe epithelial cells, whichbeginto show
large vacuoles containing casein micelles and large fat
droplets. As weaning progresses, more vacuoles appear,
enclosing a variety of subcellular organelles such as
mitochondria and fragments of endoplasmic reticulum.
Hydrolytic enzymes are released by the fusion of lyso-
somes with the vacuoles. This autophagic process leads
to cell depletion andlysis. The cell residues are ingested
by macrophages present in a quite large number in the
tissue atthisstage. However, notallofsecretoryepithelial
cells are destroyed; some of them undergo a partial au-
tophagocytosis but survive. The myoepithelial cells sur-
rounding the alveoli areusuallypreserved, although their
shape changes from starlike to a more compact form.
Determinants of Mammary Gland
Development In Vivo
The regulation of mammary gland morphogenesis in
vivo is a very complex phenomenon that involves both
hormonal stimuli and environmental factors. Tb simplify
the exposition, we have grouped underthe section "Hor-
monal Determinants" all the factors acting in an endo-
crine, autocrine, or paracrine fashion through a specific
receptor. Several factors ofmesenchymal origin seem to
affect epithelial growth in a paracrine fashion. We will
limit ourdiscussion ofthis subjecttogenericinformation;
for an extensive treatment, we refer the reader to the
specific papers in this journal.
Hormonal Determinants
In the female, mammary embryogenesis is induced by
theunderlying mesenchyme and ishormone independent.
Destruction of the ovaries with X-ray radiation in the
13-day embryo does not affect mammary development
(21). Inthe male, the mesenchyme-directed development
is interrupted at day 13, when mammary rudiments ac-
quire sensitivity to androgens; after day 15 they lose hor-
mone responsiveness. Destruction ofthe fetaltestes with
X-rays on day 13 leads to mammary development similar
to that in the female (21).
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FIGURE 2. Development of the mammary epithelial cell during pregnancy and lactation.
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Cell replication during adolescence is hormone depen-
dent(22,23). Ductalgrowth requires estrogen andeither
growth hormone or prolactin; however, neither type of
hormone is effective alone. Extensive growth can occur
in the absence ofglucocorticoid, butmaximalgrowth re-
quires the steroid. Ductal growth appears to be indepen-
dent ofprogesterone, thyroid hormones, andthe thymus
(7,24). Insulin is not involved in ductal growth invivo, as
the cells invirgin mice are notresponsive to the hormone
(25). In some species, as in the rat, the requirements for
ductalgrowth vary among the different strains (2,26,27).
17-p-Estradiol is an absolute requirement for ductal
growth, andwhenadministered to amouseitcanenhance
DNA synthesis inthe mammary epithelium. It has been
reported that the effect ofestrogen on DNA synthesis be-
gins approximately 12 hr after treatment (28), and max-
imal stimulation is reached at 48 hr. Autoradiographic
studies have shown that the increase inthymidine incor-
poration is mostly restricted to the adipose and connec-
tive tissues during the first 24 hr; at 48 and 72 hr the
epithelium undergoes extensive replication. Thus estro-
gen exerts its effect initially on stromal or fat pad cells
(28). It would be interesting to study the relationship of
this initial response to the subsequent proliferative re-
sponse of the epithelium.
There seems to be a synergism between estradiol and
cAMPin stimulatingthegrowth ofmammaryepithelium
(29); however, it is not clearwhetherthepresence ofovar-
ian hormones is necessary for cAMP to affectgrowth and
morphogenesis of the gland because of the conflicting
reports (30,31).
When the animal reaches sexual maturity, the mam-
mary tissue enters a phase of dormancy during which
only amodest replicative activity is observed at the end
buds during estrus (16). However, estriol and progester-
one administered daily to mature mice stimulate DNA
synthesis and mitosis in resting mammary epithelium
(32).
The maintenance ofductcells has differenthormonal re-
quirementsfrom ductalgrowth; apparentlypituitaryhor-
mones are not necessary when either adrenal or ovarian
activity is present (7).
Lobuloalveolar growth, which occurs mainly during
pregnancy, requires estrogen, eithergrowth hormone or
prolactin, and progesterone (1,33,34). Adrenal steroids
and thyroxine seem to enhance the formation oflobules
(7,35). Eventhoughmouse mammaryadipose and connec-
tive tissues have high affinity binding sitesfor estrogens
and progesterone, the largest amount of progesterone
receptors is present in the epithelial component (36).
Moreover, regulation ofprogesterone receptor concentra-
tionby estrogen andits changes duringthe different de-
velopmentalphases appears toberestricted to the mam-
maryepithelium (36). Ovarian steroids are also required
for maintenance of alveoli.
Onset oflactation coincidestemporallywith a decrease
in progesterone level and elevation of prolactin and
glucocorticoids. Whether thetriggerforthe onset ofmilk
production is due to the decrease incirculatingprogester-
one orto theincrease in apositive stimulus(prolactinand
glucocorticoid) is still an open question. However, lactat-
ing mammary tissue has no detectable progesterone
receptors (37,38), and, in fact, progesterone is unable to
inhibit established lactation. On the other hand, admin-
istration ofestrogen and progesterone to a lactating rat
stimulates the rate of mammary cell replication that is
similar to that observed during pregnancy (19).
Several lines of evidence support a role of epidermal
growthfactor(EGF)inmammary epithelial proliferation
duringpregnancy. Thelevel ofEGF receptors varies dur-
ing the physiological stages ofthe gland: it is relatively
low in the virgin andlactatingglands, but increases dur-
ingpregnancy and reaches apeakon day 10 ofgestation
(39).
The levels of EGF in the submandibular gland and
plasma increase substantially duringpregnancy (40). As
sialoadenectomy resultsinmarkeddecrease intheplasma
EGF, it appears that the submandibulargland serves as
a major source ofcirculating EGF. Earlier studies have
indicated that the amount ofEGF in the submandibular
gland is increased by androgens (41) andprogestins (42).
As the level ofthese steroid hormones rises duringpreg-
nancy (43), it is possible thatthe increase in submandibu-
lar EGF is elicited by the action of androgens and/or
progestin. In addition, as will be described later, physio-
logical concentrations of EGF stimulate proliferation of
mammary epithelial cells in culture.
Furtherevidence forthe involvement ofEGF in mam-
marygland development duringpregnancyisprovidedby
the work ofOkamoto and Oka(44); the mammaryglands
of lactating mice that have been sialoadenectomized
pregestationally are smaller and produce a smaller
amount ofmilk compared to that of sham-operated con-
trols. As a consequence, sialoadenectomized mothers can-
notproperly support all thelitter, andthus a substantial
number of pups die within the first week after birth.
EGF-replacement therapy given to the sialoadenec-
tomized mice during pregnancy restores the growth of
the gland, milkproduction, andpup survival rate (44,45).
Thyroid hormones seem to have a role in the mainte-
nance of alveoli and ductal branching in the involuting
gland; the mammary gland of C3H mice treated with
2-thiouracil to repress thyroid function during involution
shows less ductal branching and no alveoli (35).
Reinitiation of growth in senescent mammary
epithelium has been obtained by application ofimplants
that release cholera toxin (a cAMP-active agent) in the
gland. This implies that the growth potential is main-
tainedin the epitheliumthroughout thelife spanandthat
the change in the hormonal milieu is responsible for the
alterations ingrowthpatterns duringthe differentphys-
iological stages (46).
The Role of Stromal Components
Two different kinds ofmesenchymal cells are involved
in the morphogenesis of mammary gland epithelium of
the mouse: fat pad precursor cells and fibroblasts. The
specific interaction between fat pad precursor cells and
epithelial cells seems to beimportantfordeterminingthe
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shape ofthe ductal branching structure inthefemale em-
bryo.
The mesenchyme also plays a key role in the interrup-
tion ofdevelopment that occurs inthemale embryo: ithas
been identified as the specific target tissue for testoster-
one action, althoughitsresponsetothehormonerequires
the presence ofthe mammary epithelium (47). More re-
cent studies suggested that the mammary epithelium
could induce the formation ofandrogen receptors in the
surrounding mesenchyme, thus controlling the develop-
ment of androgen respohsiveness in the tissue (48,49).
During the massive development that occurs at sexual
maturation, epithelial-adipocyte interactions appeartobe
required for the formation of end buds and the subse-
quentmorphogenesis offullystructuredmammary ducts
White fat tissue from adifferent origin other than mam-
mary fat can support ductal growth (50,51).
Forthe epithelium to become responsive tolactogenic
hormones, certain environment-associated events must
occur. In co-culture systems of mouse mammary
epithelium and adipocytes or other fibroblasts, only
3T3L1 and3T3C2 cells couldsupport casein synthesis in
the presence of the lactogenic stimuli, insulin-cortisol-
prolactin (52). There was evidence of specificity of the
epithelium-stroma interaction duringthis stage because
Swiss 3T3 cells, newborn foreskinfibroblasts, substrate-
attachedmaterials, andtissue cultureplastic didnot sup-
portcaseinsynthesis(52). These results indicate thatthe
acquisition of hormone sensitivity and hormone-
dependent differentiation ofmammary epithelium are in-
fluencedby the stromal milieu. In cultured mouse mam-
mary explants, stroma cells appear to support the
epithelial differentiation partly by providing type I col-
lagen, an essential component ofextracellular matrix(53).
Biochemical Markers of
Differentiation In Vitro
Differentiation ofmammary epithelium is usually evalu-
ated by measuring the capacity ofthe mammary tissue
to produce the major milk proteins, such as the casein
family and a-lactalbumin.
Before the development of molecular biological tech-
niques, casein production was evaluated by im-
munoprecipitation with apolyclonal antiserum (54,55,56),
and a-lactalbumin was measured by enzymatic assays
(57,58) orimmunoprecipitation with the antibody (59,60).
The more recent approach is focused on studying tran-
scription and stability and accumulation ofspecific mes-
senger RNAsformilkproteins; cDNAs are available for
some ofthe known caseins, a-lactalbumin, andwhey acidic
protein (61-65).
The a-lactalbumin genes from man and rat have been
completely sequenced(66); partial sequences are available
for several casein genes (67). Very recently, Hall and co-
workers have compared the promoter regions of two a-
lactalbumin andfive caseingenes andhavefoundaregion
ofhigh conservation and homology spanningfrom 140 to
110 in all the sequences examined(66). The 5'flankingre-
gion, which includes the consensus sequence, is likely to
be alocus for hormonal regulation ofmilk protein genes
expression(66). The exact meaning ofthis conserved se-
quence will be elucidated by studying the expression of
milkproteingenesintransfected celllines andtransgenic
animals
Growth and Differentiation In Vitro
It has been well established that the growth and
differentiation ofmammary cells can be induced in vitro.
The in vitro systems have provided invaluable informa-
tion about the morphogenesis, growth, and differentiation
of the mammary gland.
The first model system for the study of mammary
growth and differentiation in vitro was reported in 1957
by Elias (68); this mammary explant culture system has
been widely used over the years. A whole mammary
gland culture system has been established by Ichinose
and Nandi (69); more recently, several methods for pri-
mary culture ofmammary epithelial cells have been de-
veloped. Several nonplastic substrates, such as collagen
gels (70-75), extracellular matrix (76,77), and L3TL1
adipocytes (52,78) have been used for their capacity to
support and promote mammary epithelial growth and
differentiation. Cell culture offers the opportunity to dis-
tinguishthe activity ofthe differentcellpopulations inthe
mammary gland; whole gland cultures are particularly
suitable in studying the structural changes occurring dur-
ing the various phases of development.
Mostofthe studies in culture havebeenperformed us-
ing mouse mammary tissue from animals in different
physiological stages; data obtained from in vitro experi-
ments involvingmammaryglandsfrom several other spe-
cies such asrat, rabbit, cow, andgoathave revealed some
differences in the requirements for morphological and
functional development (7).
Explant Culture
Explant culture, the first system developed, has pro-
vided infornation about the embryogenesis ofthe mam-
mary gland (5-7). Body wall fragments from the mam-
mary regionofmouse embryos at9to 10 daysofgestation
have been shown to develop mammary buds when cul-
turedon amixture ofcockbloodplasmaand chickembryo
extract (79). Under similar culture conditions, explants
with preformed buds developed branched mammary
ducts
In organ culture of mammary tissue from mouse and
rat, insulin extends cellviabilityofexplants inserum-free
medium and stimulates cell replication (25). Addition of
glucocorticoid and insulin caninduce the development of
rough endoplasmic reticulum (80-82). The expression of
the differentiated phenotype requires the addition of
prolactin (5,7,80-83). On the other hand, explants from
rabbits can synthesize casein in the presence ofprolactin
alone (84).
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Whole Gland Culture
Whole gland cultures of immature mouse mammary
gland revealed differential hormonal needs of cell sub-
populations for maintenance and development. Primary
duct cells canbe maintained andproliferate without any
added hormone, whereas secondary andtertiary ducts re-
quire insulin for maintenance and show an enchanced
proliferation in the presence of mineralcorticoid and
prolactin. Maintenance of end bud cells requires a com-
plex combination ofhormones, and proliferative activity
of these cells in vitro is modest (85).
In mouse whole gland cultures, lobuloalveolar growth
can be induced by insulin, prolactin, andglucocorticoid or
aldosterone, but the animal has to be previously primed
with estrogen and progesterone (69,86,87); residual
amounts ofsteroids carried overinto the culture could ac-
countforthe independence oflobuloalveolar formation on
the added ovarian hormones invitro. Onthe otherhand,
rat mammary gland does not require the priming with
ovarian steroids (88).
Following hormonally induced lobuloalveolar growth,
the wholegland in culture responds tothelactogenic hor-
monesby synthesizing casein. Afterthe firstround ofde-
velopment, differentiation, and regression in the whole
gland in culture, Ibnelli and Sorofwere able to induce a
second complete cycle by supplementing the serum-free
medium with EGF (89).
Cell Culture
As discussed earlier, several substrates have been
tested for their ability to support cell maintenance and
proliferation. One oftheproblems thatinvestigators have
encountered in establishing an efficient cell culture sys-
tem is reproducing the complex stromal-epithelial inter-
actions that are important for mammarygrowth invivo.
In explants and whole gland cultures these interactions
are retained, at least to some extent. Differentiation of
mammaryepithelial cells inculturerequiresproper sub-
strate such as collagen and extracellular matrix, as well
as lactogenic hormones such as insulin, glucocorticoid,
and prolactin (72-74,76).
Theepithelial cells ofthe ratembryo mammary bud at
day 16 are apparently committed as mammary cells, and
they respond to the three hormone combination by syn-
thesizingcasein(90). However, it is still not known when
they first acquire this potential. No data are available
about mouse mammary cells in embryo, but explant cul-
tures ofimmature mouse mammarygland cansynthesize
caseins (91)and accumulate lactose synthetase activity in
thepresenceofappropriate hormonal stimuli(92). Ratend
budcellsgrown oncollagen matrixwith serum and chol-
era toxin require insulin, glucocorticoid, estrogen, and
prolactin to express functional and ultrastructural
differentiation (93).
Inepithelial cell cultures frommature mouse mammary
gland, ultrastructural development anddifferentiation oc-
cur in the same hormonal conditions asintheexplant cul-
tures. Growthhormone andplacentallactogen canreplace
prolactin in this system (74,94).
Epidermalgrowthfactorandglucocorticoids can affect
the growth efficiency ofrat mammary epithelial cell cul-
tures on different substrates, apparently modifying the
rates oftype IV collagen synthesis and degradation (95).
According to McGrath et al., EGF appears to influence
the cell type and the colony shape in serum-free culture
ofnormal rat epithelial cells (96).
Maintenance of normal human breast tissue in organ
culture requires the presence of insulin, cortisol, and
prolactin orserum. Addition ofprogesterone in combina-
tion with insulin, cortisol, and prolactin to a serum-
supplemented medium provides a better condition for
epithelial growth (97). Accordingto Hillman and co-work-
ers, serum-supplemented medium enriched with insulin
and cortisol can support explants from normalmammary
tissue up to 6 months (98).
More recently, a serum-free medium containing insulin,
cortisol, EGF, andbovinepituitaryextracthasbeenfound
to be capable ofsupporting the growth ofnormal human
mammary epithelium up to 10 to 20 passages. Substitu-
tion of the bovine pituitary extract with prolactin or
prostaglandin E1 allowscell replicationfor3to 4passages
(99). Stampfer et al. reported an optimal condition for
mammary epithelial cell growth in the presence ofinsu-
lin, cortisol, EGF, and steroids that allowed the culture
to be maintained up to 3 months (100).
Hormonal requirement for in vitro maintenance varies
depending on the substratum. Yang et al. report that
epithelial cells from human mammary fibroadenomas re-
quire EGF and cortisol when cultured in three dimen-
sions into collagen gel matrix, whereas cortisol alone is
sufficient for two-dimensional growth on collagen-coated
dishes (101). In short-term monolayer culture ofnormal
human mammary epithelium, cortisol and insulin stimu-
late growth; however, the degree ofstimulation depends
on the culture substratum. Cells organized into clusters
undergo eitherinhibition ofgrowth orterminal differen-
tiation after a few passages; all isolated cells differenti-
ate. The inhibited cells can resumegrowth whengrowth
units are disrupted. This situation couldresemble the one
inmammarybuds: Theinhibitedcellsmightprovidepools
for subsequent multiple cycles of differentiation (102).
Factors Involved in Regulation of
Growth and Differentiation In Vitro
A very large amount ofexperimental data are available
today; however, the differences between the experimen-
tal systemsusedandthe complexity ofthe regulatory net-
work operating during mammary gland growth and dif-
ferentiation makes a clear organization of the subject
extremely difficult. In this section we try to summarize
the recent dataconcerningsome ofthe effectsofthe prin-
cipal agents known to affectmammary development and
function in vitro.
Insulin
In serum-free culture, insulin stimulates cell replication
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but does not seem to be necessary for ductal or alveolar
growth(103-105). Addition ofan adrenal steroid, usually
cortisol, to the culture medium induces the epithelial cells
to develop the subeellular organelles, such as the rough
endoplasmic reticulum, necessary for the synthesis and
secretion ofmilk components (80-82). However, it is only
in the presence ofprolactin thatthe tissue achieves com-
plete and functional differentiation (5,7,80-83).
Lithium ion (58,106), as well as sodium orthovanadate
(107), can mimic the stimulatory effects ofinsulin on DNA
synthesis in explant culture. On the other hand, EGF
(108)and serum(109) appeartobe abletoreplace insulin
in the induction ofboth DNA synthesis and RER forma-
tion.
By measuring parameters like glucose-6-phosphate
dehydrogenase activity and DNA synthesis, in vitro ex-
periments suggested that mouse mammary epithelial
cells invivoundergo alternatephases ofinsulinresistance
and sensitivity (25). Cells from immature ormature vir-
gin mice areinsulin insensitive butbecome responsive af-
ter 1 day in culture, regardlessthepresence ofexogenous
insulin. Mammary epithelial cells ofpregnant orlactating
mice are insulin sensitive, butloose their sensitivity dur-
ing postlactational involution (25). The modulation ofin-
sulin sensitivity in mammary tissue could therefore be a
key issue in the regulation of mammary development.
Inagaki and Kohmoto have shown that mouse mam-
mary cells possess insulin receptors with a high (Kd = 1
nM) and a low (Kd = 20 nM) affinity, and the amount of
the high affinity receptor is higher during the first half
ofpregnancy (110). Direct evidence supports the hypothe-
sis that the tyrosine kinase activity ofthe insulin recep-
tor is essential for insulin action (111).
In culture with cortisol andprolactin, insulin can induce
terminal differentiation in mouse mammary explants by
enhancingtranscription ofcaseingenes (112). Neither se-
rum(109) nor EGF (108) can substitute for insulin in the
synthesis of milk proteins in vitro. Lithium also cannot
substitute for insulin in the induction of the terminal
mammary differentiation, although the sensitivity ofthe
mammary cells to lithiumionsisgreaterinmidpregnant
than in virgin or lactating animals (58,106).
A further proofofthe involvement ofinsulin in termi-
nal differentiation is the fact thattissue from virgin mice
canundergo terminal differentiation invitro only afterit
has acquired sensitivity to insulin (25,103).
Cortisol
The concentration ofcortisol required for maximal ex-
pression ofcasein and a-lactalbumin isremarkably differ-
ent. Optimal casein production occurs in the presence of
3 MM cortisol, whereas 30 nM is sufficient for a-
lactalbumin. Moreover, cortisol concentrations ranging
from 300 nM to 3 ,M cause progressive inhibition of a-
lactalbumin accumulation (55,113). This inhibitory effect
of cortisol is reversed by prostaglandins (114). Cortisol
might have arole inregulatingthetranscription ofsome
whey protein genes; sequences bearing some resem-
blance toglucocorticoid receptorbinding sites have been
found in the 5' flanking region of human a-lactalbumin
gene (66), and potential binding sites for glucocorticoid
receptor were also found in the 5'flanking region ofthe
whey acidic protein genes of rat and mouse (115).
Cortisol can remarkably extend the half-life of casein
messenger RNA (116). In explants from rat mammary
gland cultured in the presence of insulin, cortisol, and
prolactin, glucocorticoid withdrawal reduces the half-life
ofcasein mRNA to 1 hr and also results in the decrease
oftranscription ofthe caseingene (117). The effect ofcor-
tisol on caseinmRNA is specific, since actin mRNAtran-
scription occurs normally with or without the glucocor-
ticoid (117). Cortisol also affects the lactogenic response
ofmammary tissue by regulatingprolactinbindingto the
epithelial cells (118). These findings support the hypothe-
sis ofaregulatory roleforglucocorticoids onthe differen-
tiation of mammary epithelium (5,7).
Prolactin
Prolactinisthemaindeterminant offunctional differen-
tiation ofmammary epithelium (5,7,83). Addedto amouse
mammary gland culture in combination with insulin and
glucocorticoid, prolactin induces milk protein gene ex-
pression in mammary epithelial cells. Prolactin alone is
sufficient totrigger the synthesis ofcasein inexplant cul-
ture from pregnant goats, but the efficient maintenance
ofthe cultured tissue requires insulin and cortisol (119).
The responsiveness ofmammary cells to prolactin can
be influenced by several factors. For example, cells from
midpregnantmice cultured onfloatingcollagengels show
high responsiveness toinsulin, cortisol, andprolactin and
synthesize large amounts ofcaseinforprolonged periods.
Mammary epitheliumfromvirginmice isless sensitive to
the lactogenic stimulus in culture; however, pretreatment
of the virgin mouse with progesterone for 2 weeks
produces atransient increase in responsiveness. A simi-
lareffect isproducedby applyingapituitaryallograft to
increaseprolactinlevels(120). These datasupportthecon-
ceptthatthe mammary cells' sensitivity toprolactin dur-
ing pregnancy is regulated by progesterone and prolac-
tin levels. Mammary fat pad cells appear not to be
involvedintheprocessoffunctional differentiation ofthe
epithelium (120).
The influence ofpregnancy, and lactation on the level
ofprolactinreceptors inthemammaryglandhasbeenin-
vestigated in several animal species. Ingeneral, receptor
levels are highinthemammaryglandfromvirgin animal,
decrease during pregnancy, and increase again after or
near delivery (121-123). Prolactin upregulates the num-
ber of its receptors, whereas progesterone antagonizes
this effect ofprolactin (124,125). The number ofprolactin
receptors onmammary cellsfromrabbit(122)andmouse
(121) in different developmental stages varies in inverse
relationship toprogesterone levels in serum. Glucocorti-
coidincreasesprolactinreceptorsinmammarycellsincul-
ture (118,126).
Afterbindingofprolactin to the receptor, the complex
hormone-receptor is internalized; as in the case ofEGF
and its receptor, internalization results in a downregula-
91BORELLINI AND OKA
tion ofthe receptor number (122,127,128). It is not clear
whether internalization is required for prolactin action.
It appears thus thatprolactinregulates itsreceptor level
both in a positive (129) and in a negative (127) fashion.
Prolactin is not necessary for the morphological devel-
opment ofrough endoplasmic reticulum in mouse mam-
mary gland, but it increases the RNA content in the
membranes However, prolactin hasbeen showntobenec-
essary in vivo forthe complete structural differentiation
ofmammary epithelium in cows (130). Prolactin depletion
causes only partial development of rough endoplasmic
reticulum andthe cellular areaoccupiedbyGolgi appara-
tus decreases by 11% compared to normal (130). Like in-
sulin, prolactin also appears to stimulate both ribosomal
and transfer RNA accumulation; glucocorticoid prolongs
this effect.
Growth hormone andplacental lactogen can substitute
forprolactin in epithelial cell culture ofmouse mammary
gland. Only at concentrations as high as 50,g/mL can bo-
vine growth hormone stimulate casein synthesis in goat
mammarytissuein culture(131). Bovinegrowthhormone
cannot mimic the effect ofprolactin on DNA synthesis in
goat mammary explants (131).
Explants from pregnant rats can synthesize a-lactalbu-
min in the absence of prolactin, but those from virgin
animals cannot unless the rat is pretreated with
progesterone or estrogen (132). The production of a-lac-
talbumin in response to prolactin has been also studied
in human mammary gland culture. Apparently, a-lactal-
bumin synthesis responds toprolactin stimulation in nor-
mal breast but is independent (when it occurs) ofprolac-
tin in malignant tissue. These findings suggest that
prolactin receptors could be somehow defective in malig-
nantbreast cells(133). Inmouse mammary epithelial cells
cultured on floating collagen gels, prolactin increases ion
transport across the epithelial layer, and affects passive
permeability (134,135).
Using several agents affecting calcium transport and
distribution, Bolander showed the involvement of the
calcium-calmodulin system in prolactin-induced differen-
tiation. However, this system appears not to serve as a
sole mediator ofprolaction action, since the calcium iono-
phore A23187, whichreproduces the effectofprolactin on
calcium accumulation, fails to induce differentiation in
terms of casein synthesis (136).
Very recentworkwithtubulin-binding drugsprovided
the evidence that the action ofprolactin to induce casein
geneexpression needsintegrityofthemicrotubules inthe
mammary cell (137). Colchicine desensitizes the mam-
mary epithelium to prolactin action (138).
Estrogens
17-p-Estradiol (E2) is required in vivo for both ductal
growth during sexual maturation and lobuloalveolar de-
velopment duringpregnancy(7). Inhumanbreast cellpri-
mary culture, E2 andprogesterone act as antagonists in
regulating cell multiplication (139): Estrogen acts as an
inducer of cell proliferation; progesterone shifts the
growth pattern to differentiation. In normal human
breast epithelium, E2 stimulates thegrowth ofductal sys-
tem and progesterone affects the development of acini.
Mammary cell culturesfromlactatingratsproliferate ac-
tively in response to estradiol andprogesterone at arate
similar to that ofmammary epithelium duringpregnancy
(19).
Calaf et al. reported that insulin, cortisol, and 17-p-
estradiol shorten the length ofthe cell cycle in cultured
mammary cells from human normal breast and suggested
that the cells couldbe hormonallyinduced to reenterthe
cell cycle from Go. They also reported that estrogen can
modify the length ofthe S phase and proposed that this
would account for the increase in the rate of DNA syn-
thesis caused by the ovarian hormone (140).
In explants from human mammary gland at resting
stage, estriol and estradiol caused a qualitatively differ-
entprofile ofgrowth stimulation (141). The thirdnaturally
occurring estrogen, estrone, does not show any stimula-
tory activity on thymidine uptake in cell culture (142).
Proliferating response ofnormal mammary epithelium to
estradiol is potentiated by the presence of stromal cells
(143).
Estradiol induces modifications in the plasma mem-
brane of epithelial cells; for example, the number and
length of microvilli are increased. This appears to be a
specific effect of estradiol, as progesterone, dexametha-
sone, and dihydrotestosterone are ineffective (144).
Casein synthesis and lactose synthetase activity are
stimulated by 17-p-estradiol in explant cultures ofmam-
mary gland from pregnant mice. Mammary tissue from
rats that havebeen ovariectomized and adrenalectomized
losesthe capacityto synthesize casein andto accumulate
the casein mRNA although it retains the ability to re-
spond to individual hornones (145). These data provide
the evidence forthe role ofestrogen in mediatingthe tis-
sue sensitivity to the lactogenic stimuli.
Recently, Sheffield and co-workersfoundthatthe mam-
maryglandgrowth inducedby ovarian steroids is accom-
paniedby anincrease in cAMP-dependentproteinkinase
activity and tyrosine-kinase activity (146). By contrast,
cGMP-dependentproteinphosphorylation is decreased by
progesterone but notby estrogen(146). Protein kinase C
activity shows development-related regulation; a decrease
is observed duringpregnancy and throughout lactation.
In addition, inhibitors ofprotein kinase C enhance a-lac-
talbumin production in explant culture with insulin, cor-
tisol, andprolactin(147). Invivo, variations inprotein kin-
ase C activity appear to be related to the sex steroids
ratherthanto thepeptide hormones(148). Thesefindings
indicate that the pattern of protein phosphorylation in
mammary epithelial cells undergoes substantial changes
duringmammarygrowth and differentiation, suggesting
that it may represent an important regulatory step.
Epidermal Growth Factor
As described earlier, the evidence for the involvement
of EGF in the development of the mammary gland has
been provided by several studies. EGF stimulates
proliferation ofthe epithelium in explants, whole gland,
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and cell cultures (70,89,149,150). Thymidine incorporation
is stimulated about 5-fold, and the number of epithelial
cells increases by 30 to 40%.
Like insulin, EGF actionismediatedby areceptor that
has tyrosine kinase activity. Normal mammary cells have
specific EGF receptors with a high and a low affinity
(Kd = 0.1 nM; 3.6nM)(150). The occupancy ofEGF recep-
torfor a half-maximal stimulation ofDNA synthesis was
about 10% of total receptors. Specific EGF binding to
mammary gland membranes decreases at the beginning
ofgestation, then rises around day 5 to reach amaximum
at day 10. During the second half of pregnancy and
throughout lactation, there is a constant decrease in
specific binding of EGF to the membranes. Thus EGF
receptor levels are high during the proliferative phases
ofmammary gland development and decrease when the
gland reaches functional differentiation (39). Whetherthe
mitogenic activity ofEGF requires the activation oftyro-
sine kinase is not clear.
Mouse mammary epithelial cells in culture show a spon-
taneous hyperpolarizing response when cultured in the
presence of EGF and produce a depolarizing response
whenincubatedwithinsulin(151). Thehyperpolarizing re-
sponse is mediated by activity ofa Ca2+-dependent K+
channel, whereas theionic speciesinvolvedinthe depolar-
ization response have notbeen identified (152). The hyper-
polarization induced by EGF occurspriorto cellprolifer-
ation and could be involved in the mitogenic action of
EGF.
12-O-tetradecanoylphorbol-13-acetate (TPA), a potent
tumor promoter (153), can mimic the effect of EGF on
mammary cellproliferation invitro (154). Thephorbol es-
ter canincrease the specific bindingofEGF to its recep-
tors on the mammary cell (39,150), but it is not clear
whether the stimulation occursthrough anincrease inthe
number of receptors, or rather a higher affinity of the
binding. It hasbeenproposed thatTPA couldinhibit the
downregulation of the EGF receptors (155). This effect
could be mediated by the TPA-induced kinase C activa-
tion. TPA can inhibit the production ofmilk proteins as
well. TPA and EGF decrease prolactin binding to the
epithelial cells by 50%.
When EGF is added to a culture with insulin, cortisol,
andprolactin, itinhibits the induction ofmilkproteinsby
50%. Thiseffectandthe stimulation ofDNAsynthesis are
bothobtainedbyusingaphysiological concentration ofthe
growth factor (70,150). In addition, these effects are
specific, as fibroblast growth factor, multiplication
stimulating activity, nerve growth factor, and platelet-
derivedgrowthfactorwere ineffective. EGF hasbeenalso
shown to inhibit the synthesis ofkcasein andits mRNA
accumulation in the presence ofinsulin, aldosterone, cor-
tisol, andprolactin(156). However, EGF canstimulate the
accumulation ofa-casein mRNA when prolactin is omit-
ted in mouse mammary explants (156).
EGF appears to be essential for the formation oflobu-
loalveolar structure andfor the expression ofdifferentia-
tive potential ofthe mouse mammary gland. In ovariec-
tomized and sialoadenectomized mice, replacement
therapy with ovarian steroids is not sufficient to restore
the responsiveness ofthe tissue tothelactogenic stimuli.
Moreover, the stimulatory effect ofEGF is abolished by
the absence of either 17-p-estradiol or progesterone, in-
dicating a synergistic action ofEGF and ovarian steroids
in inducing lobuloalveolar growth and in enhancing the
tissue abilityto synthesize casein(45). Mammaryexplants
from sialoadenectomized mice synthesize less casein inre-
sponse to the lactogenic stimuli (44).
EGF is very likely to play an important role in the ap-
pearance of spontaneous mammary tumors in certain
mouse strains. EGF concentration in the submandibular
gland starts raising after 30 weeks of age, and shortly
thereafter the mammary tumor incidence increases to
reachaplateau atweek52. Moreover, the tumorincidence
in mice that have been previously sialoadenectomized
dropsfrom62.5 to 13% at52weeksofage, andthelatency
in the appearance ofthe neoplasm is shifted as much as
14weeks. Even when sialoadenectomy wasperformed on
tumor-bearingmice, itresultedinarapidinhibition oftu-
morgrowth, whereas the tumorresumeditsgrowthupon
administration of EGF (157).
These results indicate that EGF stimulates prolifera-
tion ofboth normal and neoplastic growth ofmammary
epithelial cells. It has also been reported that EGF-like
substances areproducedbybreast cancer cells(158,159).
In HBL100 cells, a human mammary epithelial cell line
that binds both EGF and glucocorticoids, EGF appears
to enhancetyrosinephosphorylation oftheglucocorticoid
receptor, while dexamethasone prevents EGF effect(160).
Transforming Growth Factor P
TGF-P is a 25,000 molecular weight polypeptide found
in cultured normal cellsfrom connective tissues and var-
ious epithelia. TGJF-P can inhibit normal and cancerous
growth, but little is known about its physiological role.
When it was implanted in slow-release plasticpellets into
the developing mouse mammary gland, TGF-P inhibited
markedly mammarygrowth andmorphogenesis, and the
inhibitory effectwas fully reversible (161). These results
suggestthatTIF-p mimics anaturalnegativegrowthreg-
ulator or is itself such a regulatory agent, which an-
tagonizes the mitogenic effect ofgrowth factors such as
EGF.
Thyroid Hormones
Thyroidhormones are notnecessaryfor ductalgrowth
but seem to stimulate lobular development(7). They are
also important for maintenance ofalveoli during regres-
sion of the gland (35).
In terms of differentiation, thyroid hormones seem to
enhance the tissue responsiveness to prolactin in mouse
mammary gland by activating the prolactin receptors
both in vivo and in explant culture (162,163). In rabbit
mammary tissue, thyroid hormone enhances prolactin-
induced casein synthesis, acting probably at a posttran-
scriptional level (164). In explants from pregnant goats,
neither L-T3 nor progesterone appears to influence the
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synthesis of casein and total proteins stimulated by
prolactin (165). Thyroid hormones also regulate the level
of EGF receptors in vivo at several stages of develop-
ment. Lackofthyroid activity exerts anegative effect on
EGF binding to mammary epithelial membranes by
decreasing the number ofbinding sites (166).
The activity of thyroid hormone-binding inhibitor
(THBI), which decreases the bindingofT4 to T4-binding
globulin in serum, isreportedtobehigherinlactatingrat
mammary gland than in pregnant or virgin tissue (167).
However, itremainsunclearwhetherthehigherTHBI ac-
tivity and the consequent increase offree T4available to
thelactatingepithelium is necessary in the regulation of
lactation or whether it is just a consequence of the full
differentiation.
Retinoids
It has been reported that retinoids inhibit differentia-
tion and proliferation in the mammary gland of ex-
perimental animal (168,169). Retinoic acid, but notretinyl
acetate, can reverse the growth stimulation induced by
ovarian hormones inlactating rat mammarygland in or-
gan culture (19). By contrast, in mouse mammary ex-
plants, retinoic acidpotentiates the stimulatory effect of
epidermal growthfactor on DNA synthesis and enhances
the specific binding of EGF to its receptor (170).
Vitamin Ais known forits anticarcinogenic activity in
the mammary epithelium (171,172), but its involvement
in the functional development and maintenance of the
mammarygland needs tobe clarified. Mammary explants
from vitamin-A deficient rats show no abnormality in
producing casein and a-lactalbumin under appropriate
hormonal stimulation (173). In mammary explants from
mice, retinoic acid has no effect on casein synthesis, but
significantly decreases a-lactalbumin production in adose-
dependent fashion (170).
Progesterone alone orin combination withestrogenin-
duces aremarkable increase in cellular retinoic acid bind-
ing protein (CRABP) in vitro (174). The actions ofreti-
noids invivo may be dependent on the available amount
of CRABP in the tissue, which varies as the function of
the developmental stage andphysiological condition ofthe
animal.
Vitamin D3
The addition of vitamin D3 significantly increases
casein production in mouse mammary explants cultured
in the presence of insulin, cortisol, and prolactin (175).
Moreover, Bhattacharjee et al. found that mammary
gland explants from rachitic rats and mice show a
decreased production ofmilk proteins when cultured in
the presence ofinsulin, prolactin, andglucocorticoid(176).
Addition of 1,25-dihydroxycholecalciferol to the culture
does not reverse the reduction, whereas pretreatment of
the animal with the vitamin for 10 days can correct the
defect. DNA synthesis is not affected by vitamin D defi-
ciency (176). The action of vitamin D3 is specifically
directed to the epithelial cells, that have been shown to
concentrate the hormone intheirnuclei(177). In addition,
mouse mammaryepithelial cellshavebeen showntopos-
sess specific vitamin Dreceptors, the levelofwhichis en-
hanced by insulin, prolactin, and glucocorticoid (178).
These data strongly suggest that vitamin D3 at physio-
logical concentrations may be involved in the control of
lactogenesis.
Some Intracellular Regulatory Agents
Calcium. Anotherfactor affectingmammary growth
in short-term cultures is Ca2+concentration. Reduction
ofCa2+ to levels below 0.08 mM leads to resumption of
cell growth, but under these conditions differentiation
does not occur. The effect ofCa2+ is specific and revers-
ible (179). These findings suggest a possible modulation
of growth-differentiation pathway by alterations in cal-
cium level by such agents as phosphatidyl inositol, vita-
min D3, or prolactin which affect calcium metabolism
(180).
Polyamines. Spermidine is essential for milk protein
synthesis in vitro (181); it can substitute for glucocorti-
coid in the induction ofa-lactalbumin and, partially, casein
synthesis inculturedmouse mammary tissue. Addition of
methylglyoxalbis(guanylhydrazone) (MGBG), an inhibitor
ofpolyamine biosynthesis, to the culturemedium, causes
the inhibition ofprolactin-stimulated RNA, casein, and
lipid synthesis. The inhibition is reversed by addition of
exogenous spermidine (182).
In mammary explant cultures pretreated with insulin
and cortisol, spermidine in combination with prostaglan-
din can mimic the action ofprolactin on casein synthesis
(183). Spermidine levels, as well as ODC activity, are
elevated in response to prolactin. The requirement for
spermidine for milk protein synthesis appears to be dif-
ferent amongvarious species, butitisgenerally accepted
that spermidine plays an important role in lactogenesis.
Poly(ADP-ribose). A decreased amount ofpoly(ADP-
ribose) in the mammary gland tissue has been observed
invivo duringpregnancy andlactation, suggestinganin-
verse relationship with the differentiation process (184).
Dataobtainedfrom invitro experiments offer apossible
explanation for this decrease: in explant culture insulin
stimulates the activity ofpoly(ADP-ribosyl)glycohydro-
lase, an enzyme responsible forpoly(ADP-ribose) degra-
dation, whileprolactin appears to inhibitthe specific syn-
thetase activity. However, the role ofpoly(ADP-ribose) in
mammary differentiation is unclear, as pharmacological
inhibition ofpoly(ADP-ribosyl) synthetase results in an
increase in a-lactalbumin accumulation (184,185).
Concluding Remarks
In this paper we have reviewed the recent literature
related to the control of growth and differentiation of
mammarygland. Experimental systemsemployed to as-
sess the contribution of hormones and growth factors
have been quite diverse, involving both in vivo and in
vitro systems, animalsfrom differentspeciesand strains
and, morerecently, several celllines derivedfrom normal
or neoplastic tissue.
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The most widely used approach in studies invivo is to
induce a specific hormonal deficiency and thento observe
the ability ofthe mammary tissue to undergo the phys-
iological changes related topregnancy andlactation. The
deficient condition maybe obtainedby differentmethods,
such as surgical removal ofthe main hormonal source or
antibodies against the hormone orits receptor. Replace-
ment therapy canprovide further information about the
function ofthe specific factor studied. These approaches
have been used in the recent study ofthe role ofEGF in
mammary gland during pregnancy.
In vitro systems have been successfully used to study
the directinvolvementofvarious hormones. Itispossible
to maintain mammary cells inthevarious culture systems
using chemically defined medium and to monitor the de-
gree of differentiation ofthe mammary tissue by meas-
uringtheproduction ofmilkproteins andtheirrespective
mRNA. These simplified systems have helped, atleast to
some extent, to clarify the contribution ofthe individual
regulatory factors.
The mode ofinteractions amonghormones andgrowth
factors is different andvaries withthephysiological con-
dition ofthe gland. Estrogens may be considered as the
main effectors of mammary epithelial growth; however,
the cell sensitivity to estrogen is controlled byprogester-
one or vice versa. In addition, recent studies have re-
vealed the importance ofEGF as mammary cell growth
factor duringpregnancy. It is alsonoteworthy thatitspro-
duction is regulated by ovarian steroids.
Onthe otherhand, prolactinplaysthemajorrole inthe
induction of differentiation. Its receptor is regulated by
some other hormones andgrowthfactors such as insulin,
glucocorticoid, andEGF. From these studies itisbecom-
ingmore evident that hormone andgrowthfactorrecep-
tors are notjustpassive carriers ofamessagebut can ac-
tually modulate the signal by participating in complex
regulatory circuits involving intracellular transmitters.
Receptors are perhaps the main communication system
through which mammary cells can adapt their behavior
to the surrounding environment, and defective receptors
are likely to be responsible for some kinds ofmammary
hyperplasia.
In the past, knowledge ofthe specific roles ofdifferent
regulators ofmammaryfunction wasmainlylimitedtothe
descriptionoftheireffects oncellphenotypeandcellphys-
iology. The morepowerful techniques now available allow
us tofocus onunderstanding howintracellularmediators
are related to exogenous stimuli; on the other hand
several current studies are tryingto elucidate when and
how determinants ofmammary cellgrowth and differen-
tiation are interacting with the processes ofDNA repli-
cation, transcription and message translation.
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